Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KAT7 | O95251 | 17/20 | 0.41 |
| ▸ | KAT6A | Q92794 | 17/20 | 0.41 |
| ▸ | KAT6B | Q8WYB5 | 12/20 | 0.41 |
| ▸ | KAT5 | Q92993 | 9/20 | 0.41 |
| ▸ | KAT8 | Q9H7Z6 | 9/20 | 0.41 |
| ▸ | NR3C1 | P04150 | 2/20 | 0.39 |
| ▸ | PGR | P06401 | 2/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | TP53 | P04637 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | HPGD | P15428 | 1/20 | 0.39 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23631795 | 0.87 | KAT7 (0.43) | KAT7KAT6AKAT6BKAT5KAT8 | |
| SCHEMBL23635883 | 0.82 | KDM4E (0.50) | KAT7KAT6AKAT6BKAT5KAT8 | |
| SCHEMBL23631827 | 0.81 | ALDH1A1 (0.51) | LMNATP53MAPTHPGDNPSR1 | |
| SCHEMBL23631813 | 0.81 | KMT2A (0.47) | KAT7KAT6AKAT6BKAT5KAT8 | |
| SCHEMBL23635956 | 0.81 | MAPT (0.47) | KAT7KAT6ANR3C1PGRTP53 | |
| SCHEMBL23635850 | 0.81 | NR3C1 (0.41) | KAT7KAT6AKAT6BKAT5KAT8 | |
| SCHEMBL30842111 | 0.80 | KAT7 (0.65) | KAT7KAT6AKAT6BKAT5KAT8 | |
| SCHEMBL23635958 | 0.80 | KAT7 (0.65) | KAT7KAT6AKAT6BKAT5KAT8 | |
| SCHEMBL23292514 | 0.79 | TSHR (0.46) | KAT7KAT6AKAT6BKAT5KAT8 | |
| SCHEMBL23631841 | 0.78 | RAB9A (0.46) | KAT6ATP53MAPTHPGDNPSR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210213004-A1 | Compounds | CTXT PTY LTD (AU) | 2021-07-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210213004-A1 | Compounds | SLC10A1, ABCB11, REN | KAT7 490/4885KAT6A 951/4885KAT6B 766/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.